For nearly 100 years, Merck and Merck KGaA have been independent entities, but their shared name has led to confusion, sniping and even legal fracas. Now the two former relatives are working behind closed doors to smooth things over, Bloomberg reports, but don’t expect either to bend much on the issue of identity.
Fast-growing R&D services outfit WuXi PharmaTech is marching ahead with plans to wrap a $250 million venture fund aimed at U.S. and China life sciences companies. WuXi filed documents with the SEC last week outlining the goal for WuXi Healthcare Ventures Fund II, which it’s already made a $50 million anchor investment in. …read more […]